Sort
10,766 grants matching “checkpoint inhibitor”
Radiation-induced translational control of gene expression
$866,564Philip Tofilon · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Mesothelin-targeted immunotoxins in Pancreatic Cancer
$863,617Christine Alewine · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Radiation-induced translational control of gene expression
$863,575Philip Tofilon · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Enhancing Cancer Immunotherapy: Targeting the Tumor and Targeting the Host
$863,419Ronald Levy · Stanford University · R35 · FY2020 · CA
BCMA Specific Chimeric Antigen Receptor (CAR)-T Cells for Treatment of Patients with Multiple Myeloma
$862,729Damian J. Green · Fred Hutchinson Cancer Center · P01 · FY2022 · CA
Software for predicting liver injury from biologics drug candidates using data from a human liver microphysiology system
$862,693Kyunghee Yang · Simulations Plus, Inc. · R44 · FY2022 · TR
Subcellular protein localization in B. subtilis
$862,568Kumaran Ramamurthi · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Selective Targeting of the PD-1+ HIV/SIV reservoir with novel anti-PD-1 chimeric antigen receptor T cells
$862,398Karsten Eichholz · Fred Hutchinson Cancer Center · R01 · FY2025 · AI
Small molecule enhancers of tumor immunity targeting the LPA5 GPCR
$861,845Gabor J Tigyi · University Of Tennessee Health Sci Ctr · R01 · FY2022 · CA
Understanding IDH mutant gliomas
$859,926Jing Wu · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
SPORE in Myeloid Malignancies
$859,786Benjamin Levine Ebert · Dana-Farber Cancer Inst · P50 · FY2018 · CA
Mechanisms of chromosome segregation, aneuploidy, and tumorigenesis
$858,918Don W. Cleveland · Ludwig Institute For Cancer Res Ltd · R35 · FY2021 · GM
Mechanisms of chromosome segregation, aneuploidy, and tumorigenesis
$858,918Don W. Cleveland · Ludwig Institute For Cancer Res Ltd · R35 · FY2018 · GM
Mechanisms of chromosome segregation, aneuploidy, and tumorigenesis
$858,918Don W. Cleveland · Ludwig Institute For Cancer Res Ltd · R35 · FY2020 · GM
Mechanisms of chromosome segregation, aneuploidy, and tumorigenesis
$858,918Don W. Cleveland · Ludwig Institute For Cancer Res Ltd · R35 · FY2019 · GM
Regulation of innate lymphocyte function
$858,430Eric O Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Decoding T cell clonotypes, biology and predictive biomarkers associated with immune checkpoint Myocarditis
$858,186Alexandra-Chloe Villani · Massachusetts General Hospital · R01 · FY2025 · AI
Cancer Immunotherapy Clinical Trials
$858,075Christopher Heery · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Cell-free assay technologies for the identification of active compounds
$857,347Barry Okeefe · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Study of the Roles of SDF1 and CXCR4 in Hematopoiesis
$856,318Giovanna Tosato · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Liver Cancer Program
$856,127Xin Wei Wang · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Development of Tumor and Immuno-Metabolism Based Small Molecule Therapeutics for Refractory Breast Cancer
$854,530Vincent Sandanayaka · Nirogyone Therapeutics, Llc · R44 · FY2021 · CA
Enhancing Cancer Immunotherapy: Targeting the Tumor and Targeting the Host
$853,049Ronald Levy · Stanford University · R35 · FY2019 · CA
Role of Pancreatic Elastase in Beta Cell Health, Autoimmunity and Type 1 Diabetes
$852,465Scott A Oakes · University Of Chicago · U01 · FY2025 · DK
Process Development and Preclinical Advancement of a Novel Nanoparticle Formulation for Immune Activation
$850,188Richard Johnson · Saros Therapeutics Inc · R44 · FY2024 · CA